Commodore Capital LP Diversified Active

CIK: 0001831942 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value ($000): $2,048,436 (100.0% shares, 0.0% debt)

Holdings (37)

— MERUS N V 16.2%

Value ($000) $331,879 Shares 3,525,000 Est. Cost $29.97 Unrealized —

NUVL NUVALENT INC 5.9%

Value ($000) $121,072 Shares 1,400,000 Est. Cost $67.32 Unrealized +17.4%

XENE XENON PHARMACEUTICALS INC 5.3%

Value ($000) $108,405 Shares 2,700,000 Est. Cost $30.82 Unrealized +14.3%

COGT COGENT BIOSCIENCES INC 5.1%

Value ($000) $104,110 Shares 7,250,000 Est. Cost $10.67 Unrealized +11.1%

ELVN ENLIVEN THERAPEUTICS INC 4.7%

Value ($000) $96,062 Shares 4,692,809 Est. Cost $19.08 Unrealized +5.6%

AGIO AGIOS PHARMACEUTICALS INC 4.6%

Value ($000) $93,859 Shares 2,338,287 Est. Cost $33.00 Unrealized +14.0%

ALKS ALKERMES PLC 4.5%

Value ($000) $92,903 Shares 3,096,754 Est. Cost $26.85 Unrealized +5.0%

SLNO SOLENO THERAPEUTICS INC 4.5%

Value ($000) $91,260 Shares 1,350,000 Est. Cost $58.91 Unrealized +25.8%

RLAY RELAY THERAPEUTICS INC 4.3%

Value ($000) $88,740 Shares 17,000,000 Est. Cost $3.15 Unrealized +20.9%

CLDX CELLDEX THERAPEUTICS INC NEW 3.8%

Value ($000) $78,343 Shares 3,028,335 Est. Cost $22.13 Unrealized +4.7%

CNTA CENTESSA PHARMACEUTICALS PLC 3.4%

Value ($000) $69,113 Shares 2,850,000 Est. Cost $15.31 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 3.4%

Value ($000) $69,056 Shares 3,200,000 Est. Cost $15.97 Unrealized +13.0%

PTGX PROTAGONIST THERAPEUTICS INC 3.3%

Value ($000) $68,091 Shares 1,025,000 Est. Cost $47.99 Unrealized +18.4%

PHVS PHARVARIS N V 2.9%

Value ($000) $60,341 Shares 2,418,476 Est. Cost $22.98 Unrealized -3.5%

— CIDARA THERAPEUTICS INC 2.7%

Value ($000) $56,020 Shares 585,000 Est. Cost $48.71 Unrealized —

AMLX AMYLYX PHARMACEUTICALS INC 2.7%

Value ($000) $55,386 Shares 4,075,478 Est. Cost $9.41 Unrealized 0.0%

TYRA TYRA BIOSCIENCES INC 2.3%

Value ($000) $47,216 Shares 3,375,000 Est. Cost $10.62 Unrealized +7.3%

TERN TERNS PHARMACEUTICALS INC 2.1%

Value ($000) $42,807 Shares 5,700,000 Est. Cost $6.39 Unrealized 0.0%

KYMR KYMERA THERAPEUTICS INC 2.1%

Value ($000) $42,450 Shares 750,000 Est. Cost $34.43 Unrealized +31.0%

— MIND MEDICINE MINDMED INC 1.9%

Value ($000) $38,023 Shares 3,225,000 Est. Cost $8.32 Unrealized —

NRIX NURIX THERAPEUTICS INC 1.7%

Value ($000) $34,928 Shares 3,780,055 Est. Cost $21.29 Unrealized -51.2%

ORKA ORUKA THERAPEUTICS INC 1.6%

Value ($000) $33,711 Shares 1,753,054 Est. Cost $30.70 Unrealized -51.7%

SYRE SPYRE THERAPEUTICS INC 1.6%

Value ($000) $33,320 Shares 1,988,084 Est. Cost $14.79 Unrealized +10.3%

DRUG BRIGHT MINDS BIOSCIENCES INC 1.5%

Value ($000) $30,330 Shares 500,000 Est. Cost $35.19 Unrealized +10.3%

ASMB ASSEMBLY BIOSCIENCES INC 1.2%

Value ($000) $25,600 Shares 1,000,000 Est. Cost $21.94 Unrealized 0.0%

CTMX CYTOMX THERAPEUTICS INC 1.2%

Value ($000) $24,538 Shares 7,692,300 Est. Cost $1.61 Unrealized +39.7%

LBRX LB PHARMACEUTICALS INC 1.2%

Value ($000) $23,685 Shares 1,500,000 Est. Cost $15.87 Unrealized 0.0%

TNGX TANGO THERAPEUTICS INC 0.6%

Value ($000) $12,600 Shares 1,500,000 Est. Cost $2.47 Unrealized +173.7%

APGE APOGEE THERAPEUTICS INC 0.6%

Value ($000) $11,522 Shares 290,000 Est. Cost $25.01 Unrealized +52.6%

PEPG PEPGEN INC 0.5%

Value ($000) $10,891 Shares 2,357,319 Est. Cost $1.61 Unrealized 0.0%

ENTA ENANTA PHARMACEUTICALS INC 0.5%

Value ($000) $9,576 Shares 800,000 Est. Cost $7.99 Unrealized 0.0%

SABS SAB BIOTHERAPEUTICS INC 0.4%

Value ($000) $8,847 Shares 4,401,500 Est. Cost $2.26 Unrealized 0.0%

IKT INHIBIKASE THERAPEUTICS INC 0.4%

Value ($000) $8,744 Shares 5,397,488 Est. Cost $2.49 Unrealized -30.6%

PCSC PERCEPTIVE CAP SOLUTIONS COR 0.4%

Value ($000) $7,920 Shares 750,000 Est. Cost $10.07 Unrealized +5.1%

AVTX AVALO THERAPEUTICS INC 0.3%

Value ($000) $6,139 Shares 483,000 Est. Cost $10.53 Unrealized -18.3%

VTGN VISTAGEN THERAPEUTICS INC 0.3%

Value ($000) $5,591 Shares 1,575,000 Est. Cost $4.44 Unrealized -32.7%

CBIO CRESCENT BIOPHARMA INC. 0.3%

Value ($000) $5,360 Shares 450,829 Est. Cost $21.15 Unrealized -37.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	MERUS N V	3,525,000	$331,879	16.2%	$29.97	—	COM	N5749R100
NUVL	NUVALENT INC	1,400,000	$121,072	5.9%	$67.32	+17.4%	COM	670703107
XENE	XENON PHARMACEUTICALS INC	2,700,000	$108,405	5.3%	$30.82	+14.3%	COM	98420N105
COGT	COGENT BIOSCIENCES INC	7,250,000	$104,110	5.1%	$10.67	+11.1%	COM	19240Q201
ELVN	ENLIVEN THERAPEUTICS INC	4,692,809	$96,062	4.7%	$19.08	+5.6%	COM	29337E102
AGIO	AGIOS PHARMACEUTICALS INC	2,338,287	$93,859	4.6%	$33.00	+14.0%	COM	00847X104
ALKS	ALKERMES PLC	3,096,754	$92,903	4.5%	$26.85	+5.0%	SHS	G01767105
SLNO	SOLENO THERAPEUTICS INC	1,350,000	$91,260	4.5%	$58.91	+25.8%	COM	834203309
RLAY	RELAY THERAPEUTICS INC	17,000,000	$88,740	4.3%	$3.15	+20.9%	COM	75943R102
CLDX	CELLDEX THERAPEUTICS INC NEW	3,028,335	$78,343	3.8%	$22.13	+4.7%	COM NEW	15117B202
CNTA	CENTESSA PHARMACEUTICALS PLC	2,850,000	$69,113	3.4%	$15.31	—	SPONSORED ADS	152309100
VRDN	VIRIDIAN THERAPEUTICS INC	3,200,000	$69,056	3.4%	$15.97	+13.0%	COM	92790C104
PTGX	PROTAGONIST THERAPEUTICS INC	1,025,000	$68,091	3.3%	$47.99	+18.4%	COM	74366E102
PHVS	PHARVARIS N V	2,418,476	$60,341	2.9%	$22.98	-3.5%	COM	N69605108
—	CIDARA THERAPEUTICS INC	585,000	$56,020	2.7%	$48.71	—	COM NEW	171757206
AMLX	AMYLYX PHARMACEUTICALS INC	4,075,478	$55,386	2.7%	$9.41	0.0%	COM	03237H101
TYRA	TYRA BIOSCIENCES INC	3,375,000	$47,216	2.3%	$10.62	+7.3%	COM	90240B106
TERN	TERNS PHARMACEUTICALS INC	5,700,000	$42,807	2.1%	$6.39	0.0%	COM	880881107
KYMR	KYMERA THERAPEUTICS INC	750,000	$42,450	2.1%	$34.43	+31.0%	COM	501575104
—	MIND MEDICINE MINDMED INC	3,225,000	$38,023	1.9%	$8.32	—	COM NEW	60255C885
NRIX	NURIX THERAPEUTICS INC	3,780,055	$34,928	1.7%	$21.29	-51.2%	COM	67080M103
ORKA	ORUKA THERAPEUTICS INC	1,753,054	$33,711	1.6%	$30.70	-51.7%	COM	687604108
SYRE	SPYRE THERAPEUTICS INC	1,988,084	$33,320	1.6%	$14.79	+10.3%	COM NEW	00773J202
DRUG	BRIGHT MINDS BIOSCIENCES INC	500,000	$30,330	1.5%	$35.19	+10.3%	COM NEW	10919W405
ASMB	ASSEMBLY BIOSCIENCES INC	1,000,000	$25,600	1.2%	$21.94	0.0%	COM NEW	045396207
CTMX	CYTOMX THERAPEUTICS INC	7,692,300	$24,538	1.2%	$1.61	+39.7%	COM	23284F105
LBRX	LB PHARMACEUTICALS INC	1,500,000	$23,685	1.2%	$15.87	0.0%	COM SHS	50180M108
TNGX	TANGO THERAPEUTICS INC	1,500,000	$12,600	0.6%	$2.47	+173.7%	COM	87583X109
APGE	APOGEE THERAPEUTICS INC	290,000	$11,522	0.6%	$25.01	+52.6%	COM	03770N101
PEPG	PEPGEN INC	2,357,319	$10,891	0.5%	$1.61	0.0%	COM	713317105
ENTA	ENANTA PHARMACEUTICALS INC	800,000	$9,576	0.5%	$7.99	0.0%	COM	29251M106
SABS	SAB BIOTHERAPEUTICS INC	4,401,500	$8,847	0.4%	$2.26	0.0%	COM NEW	78397T202
IKT	INHIBIKASE THERAPEUTICS INC	5,397,488	$8,744	0.4%	$2.49	-30.6%	COM NEW	45719W205
PCSC	PERCEPTIVE CAP SOLUTIONS COR	750,000	$7,920	0.4%	$10.07	+5.1%	CL A ORD SHS	G70077105
AVTX	AVALO THERAPEUTICS INC	483,000	$6,139	0.3%	$10.53	-18.3%	COM NEW	05338F306
VTGN	VISTAGEN THERAPEUTICS INC	1,575,000	$5,591	0.3%	$4.44	-32.7%	COM	92840H400
CBIO	CRESCENT BIOPHARMA INC.	450,829	$5,360	0.3%	$21.15	-37.3%	COM	G2545C104